Mette Ølgod Pedersen

Author

Also Known As

M Pedersen, M. Pedersen, M.Ø. Pedersen, Maja Chieng Frisenberg Pedersen, Mette Ølgod Pedersen, Mette Pedersen, Mette Ø Pedersen, Mette Ø. Pedersen, Mette Ølgod Pedersen, Mette ølgod Pedersen

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Herlev Hospital Rigshospitalet Gentofte Hospital University of Copenhagen Copenhagen University Hospital

MØ

About

Mette Ølgod Pedersen is an author at Herlev Hospital specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.5K
2	Immunology	5	5	1.4K
3	Cell Biology	3	3	1.3K
4	Natural Sciences	1	1	43
5	Molecular Biology	1	1	43

Mette Ølgod Pedersen

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma Anupama Reddy, Jenny Zhang, Nicholas S. Davis, Cell Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseMedicineImmunology	2017	1.1K
<scp>MYC</scp> translocation partner gene determines survival of patients with large B‐cell lymphoma with <scp>MYC</scp>‐ or double‐hit <scp>MYC</scp>/<scp>BCL</scp>2 translocations Mette Ølgod Pedersen, Anne Ortved Gang, Tim Svenstrup Poulsen, European Journal Of Haematology Split ProbesMixed-phenotype Acute LeukemiaImmunologyPathologyImmunotherapy	2013	120
Double‐hit <scp>BCL</scp>2/<scp>MYC</scp> translocations in a consecutive cohort of patients with large B‐cell lymphoma – a single centre's experience Mette Ølgod Pedersen, Anne Ortved Gang, Tim Svenstrup Poulsen, European Journal Of Haematology Double HitLymphoid NeoplasiaLarge B‐cell LymphomaHematological MalignancyMedicine	2012	98
Increased Prevalence of Leukocytes and Elevated Cytokine Levels in Semen from<i>Schistosoma haematobium</i>–Infected Individuals Peter Derek Christian Leutscher, Mette Ølgod Pedersen, C Raharisolo, The Journal of Infectious Diseases	2005	84
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group Anne Ortved Gang, Camilla Strøm, Mette Ølgod Pedersen, Annals of Oncology Hematological MalignancyPopulation-based InvestigationLymphoid NeoplasiaMedicineHematology	2011	76
Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma Agoston Gyula Szabo, Anne Ortved Gang, Mette Ølgod Pedersen, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyMyc TranslocationMedicineMalignant Blood DisorderImmunology	2016	55
Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules Z. Berke, MH Andersen, Mette Ølgod Pedersen, Leukemia HistocompatibilityBcr/abl FusionJunctional RegionMedicineNatural Sciences	2000	43
Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP Pekka Peroja, Mette Ølgod Pedersen, Tuomo Mantere, Scientific Reports	2018	30
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers Mette Ølgod Pedersen PLoS ONE	2017	19
Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma Anne Ortved Gang, Mette Ølgod Pedersen, Helle Knudsen, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyLymphoid NeoplasiaHigh-risk DlbclEtoposide-containing ChemotherapyDanish Lymphoma Database	2014	14

Page 1